相似文献
1
Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update.
Genes (Basel). 2022 Dec 16;13(12):2388. doi: 10.3390/genes13122388.
2
The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence?
Genes (Basel). 2023 May 27;14(6):1167. doi: 10.3390/genes14061167.
3
Immunoepigenetic Regulation of Inflammatory Bowel Disease: Current Insights into Novel Epigenetic Modulations of the Systemic Immune Response.
Genes (Basel). 2023 Feb 23;14(3):554. doi: 10.3390/genes14030554.
4
Familial occurrence and inheritance studies in inflammatory bowel disease.
Neth J Med. 1996 Feb;48(2):53-6. doi: 10.1016/0300-2977(95)00093-3.
5
Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.
Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:2-10. doi: 10.1111/j.1365-2036.2006.03052.x.
6
Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.
Dig Dis Sci. 2001 Mar;46(3):632-6. doi: 10.1023/a:1005623904826.
7
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome.
J Crohns Colitis. 2023 Mar 18;17(2):170-184. doi: 10.1093/ecco-jcc/jjac127.
8
A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.
Inflamm Bowel Dis. 2003 Jan;9(1):1-9. doi: 10.1097/00054725-200301000-00001.
9
Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel Disease.
Curr Pharm Des. 2021;27(35):3702-3713. doi: 10.2174/1381612827666210218141847.
10
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Lancet. 1996 May 4;347(9010):1212-7. doi: 10.1016/s0140-6736(96)90734-5.
引用本文的文献
1
Role of ETS2 gene in inflammatory bowel disease: A narrative review.
Medicine (Baltimore). 2025 Sep 5;104(36):e44234. doi: 10.1097/MD.0000000000044234.
2
Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease.
Int J Mol Sci. 2025 Aug 14;26(16):7860. doi: 10.3390/ijms26167860.
3
Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application.
Front Med (Lausanne). 2025 Aug 1;12:1620079. doi: 10.3389/fmed.2025.1620079. eCollection 2025.
4
Advancements in Immunomodulatory Therapies for IBD and Their Interplay With the Gut-Brain Axis: An Updated Review of Current Literature and Beyond.
Health Sci Rep. 2025 Aug 10;8(8):e71157. doi: 10.1002/hsr2.71157. eCollection 2025 Aug.
5
Synergistic Effect of Nanoparticles with Probiotics on Gastrointestinal Regenerative Medicine.
Probiotics Antimicrob Proteins. 2025 Aug 8. doi: 10.1007/s12602-025-10707-y.
6
Postbiotics as Mitochondrial Modulators in Inflammatory Bowel Disease: Mechanistic Insights and Therapeutic Potential.
Biomolecules. 2025 Jul 1;15(7):954. doi: 10.3390/biom15070954.
7
Pharmacoepigenetic Biomarkers in Inflammatory Bowel Diseases: A Narrative Review.
Yale J Biol Med. 2025 Jun 30;98(2):171-186. doi: 10.59249/FTXB7704. eCollection 2025 Jun.
8
Phenolic Profiling and Bioactive Properties of Extract in Alleviating Acute and Sub-Chronic Colitis.
Int J Mol Sci. 2025 Jun 13;26(12):5692. doi: 10.3390/ijms26125692.
9
The importance of ALPK1 kinase functionality as a potential biomarker for inflammatory diseases.
Mol Biol Rep. 2025 Jun 10;52(1):575. doi: 10.1007/s11033-025-10528-w.
10
Angiogenic Factors and Inflammatory Bowel Diseases.
Biomedicines. 2025 May 9;13(5):1154. doi: 10.3390/biomedicines13051154.
本文引用的文献
1
Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease.
J Crohns Colitis. 2023 Mar 18;17(2):185-198. doi: 10.1093/ecco-jcc/jjac119.
2
Inflammatory bowel disease in families with four or more affected first-degree relatives.
Scand J Gastroenterol. 2023 Jan;58(1):20-24. doi: 10.1080/00365521.2022.2106153. Epub 2022 Aug 5.
3
Epigenetics in IBD: a conceptual framework for disease pathogenesis.
Frontline Gastroenterol. 2022 Jun 7;13(e1):e22-e27. doi: 10.1136/flgastro-2022-102120. eCollection 2022.
4
Does the road to primary prevention of inflammatory bowel disease start from childhood?
JGH Open. 2022 Jun 22;6(6):365-368. doi: 10.1002/jgh3.12782. eCollection 2022 Jun.
5
Deletion of both Dectin-1 and Dectin-2 affects the bacterial but not fungal gut microbiota and susceptibility to colitis in mice.
Microbiome. 2022 Jun 14;10(1):91. doi: 10.1186/s40168-022-01273-4.
6
Age determines the risk of familial inflammatory bowel disease-A nationwide study.
Aliment Pharmacol Ther. 2022 Aug;56(3):491-500. doi: 10.1111/apt.16938. Epub 2022 Apr 22.
7
Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
Int J Mol Sci. 2022 Mar 23;23(7):3464. doi: 10.3390/ijms23073464.
8
New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease.
Front Pharmacol. 2022 Jan 31;13:813659. doi: 10.3389/fphar.2022.813659. eCollection 2022.
9
Methylation quantitative trait loci are largely consistent across disease states in Crohn's disease.
G3 (Bethesda). 2022 Apr 4;12(4). doi: 10.1093/g3journal/jkac041.
10
IBD-Associated Atg16L1T300A Polymorphism Regulates Commensal Microbiota of the Intestine.
Front Immunol. 2022 Jan 27;12:772189. doi: 10.3389/fimmu.2021.772189. eCollection 2021.
Zotero 插件